首页>
外国专利>
USE OF RECOMBINANT GANODERMA LUCIDUM IMMUNOREGULATORY PROTEIN IN PREPARATION OF MEDICAMENT FOR TREATING ANDROGENETIC ALOPECIA
USE OF RECOMBINANT GANODERMA LUCIDUM IMMUNOREGULATORY PROTEIN IN PREPARATION OF MEDICAMENT FOR TREATING ANDROGENETIC ALOPECIA
展开▼
机译:重组灵芝免疫调节蛋白在制备治疗雄激素性白内障的药物中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed is a use of recombinant Ganoderma lucidum immunoregulatory protein (rLZ-8) in the preparation of a medicament for treating androgenetic alopecia. It is shown by in vivo animal model experiments that the recombinant Ganoderma lucidum immunoregulatory protein can improve hair loss in animal models with androgenetic alopecia, and can be used for preventing and treating androgenetic alopecia. The recombinant Ganoderma lucidum immunoregulatory protein of the present invention is a protein substance with a high purity prepared by a recombination technology and yeast cell eukaryotic expression system.
展开▼